Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention.
Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance of information to uncover new opportunities and understand why certain stocks should be of interest.
Here's a look at the Benzinga Stock Whisper Index for the week of Nov. 8:
Insmed also said its NDA submission for Brensocatib in Bronchiectasis is on track for the fourth quarter and is expected to launch in the U.S. in mid-2025.
Insmed shares were up over 8% in the last five trading days, as seen on the Benzinga Pro chart below, and are up over 140% year-to-date in 2024.
Analysts raised their price targets on the stock after the quarterly results. The stock was up over 15% in the last five trading days and is up over 50% year-to-date in 2024.
The company said the third quarter was exceptional and CEO Jack Sinclair highlighted "robust traffic growth." Same store sales were up 8.4% in the third quarter. The company opened nine new stores, ending the quarter with 428 stores in 23 states.
Goldman Sachs recently maintained a Buy rating on the stock and raised the price target from $127 to $159. Wells Fargo maintained an Equal-Weight rating on the stock and raised the price target from $90 to $130.
The stock was up over 10% over the last five trading days, and shares are up over 190% year-to-date in 2024.
Intuitive Surgical (NASDAQ:ISRG): The medical devices company saw strong interest from readers over the last week, with shares trading at 52-week highs Friday.
The company also placed 379 da Vinci systems in the quarter, up from 312 in the prior quarter. There are 9,539 installed da Vinci surgical systems as of the end of the quarter. Intuitive obtained regulatory clearance for the da Vinci 5 surgical system in South Korea in October.
"We anticipated that declining interest rates and moderating inflation, combined with the resolution of election related uncertainty, will create a more stable and favorable environment for us," Mueller CEO Greg Christopher said.
The stock was up 13% over the last five days and is up over 100% year-to-date in 2024.
Stay tuned for next week’s report, and follow Benzinga Pro for all the latest headlines and top market-moving stories here.
Read the latest Stock Whisper Index reports here:
Read Next:
Photo: Benzinga
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
